GUSA News and Press, Goldman Sachs MarketBeta U.S. 1000 Equity ETF From 05/10/22

Bausch Health has seen a very tough 2022 as investors price in higher interest rates on its massive debt load and softer IPO of its subsidiary Bausch + Lomb. These are not encouraging trends, but the valuation reset has been enormous, potentially creating an opportunistic investment o...

Block reported first quarter results that missed estimates on a number of items. This has resulted in analysts cutting estimates for 2022 and 2023. It cannot be ruled out of this stock returning to its pandemic lows. For further details see: Block May Be Heading Back To ...

UNH recently reported earnings that were a beat and raise. Beat and raise seems to be a regular occurrence for this company when they announce earnings. This stock has been a dividend growth machine fueled by these earning beats. For further details see: UnitedHealth Gro...